These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4039649)

  • 21. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL; Bigelow GE; Bickel WK; Liebson IA
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.
    Woods JH; Young AM; Herling S
    Fed Proc; 1982 Feb; 41(2):221-7. PubMed ID: 7037459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM; McNiel DM
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The enflurane sparing effect of morphine, butorphanol, and nalbuphine.
    Murphy MR; Hug CC
    Anesthesiology; 1982 Dec; 57(6):489-92. PubMed ID: 7149306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
    Sell SL; McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor.
    Smith MA; Barrett AC; Picker MJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):261-9. PubMed ID: 10353428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self administration: positive and negative reinforcing properties of morphine antagonists in rhesus monkeys.
    Hoffmeister F; Wuttke W
    Adv Biochem Psychopharmacol; 1973; 8(0):361-9. PubMed ID: 4212335
    [No Abstract]   [Full Text] [Related]  

  • 32. kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
    Vivian JA; DeYoung MB; Sumpter TL; Traynor JR; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Jul; 290(1):259-65. PubMed ID: 10381785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the stimulus effects of codeine in rhesus monkeys under the contingencies of a two lever discrimination task and a cross self-administration paradigm: tests of generalization to pentazocine, buprenorphine, tilidine, and different doses of codeine.
    Hoffmeister F
    Psychopharmacology (Berl); 1988; 94(3):315-20. PubMed ID: 3128807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of prototypical opioid antagonists, agonist-antagonists, and agonists in the morphine-dependent rhesus monkey.
    Aceto MD
    Neuropeptides; 1984 Dec; 5(1-3):15-8. PubMed ID: 6099486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
    Cowan A
    Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992
    [No Abstract]   [Full Text] [Related]  

  • 36. Physical dependence induced by opiate partial agonists in the rat.
    McCarthy PS; Howlett GJ
    Neuropeptides; 1984 Dec; 5(1-3):11-4. PubMed ID: 6152317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Full ยต-Opioid Receptor Agonists is not Impaired by Concomitant Buprenorphine or Mixed Opioid Agonists/Antagonists - Preclinical and Clinical Evidence.
    van Niel JC; Schneider J; Tzschentke TM
    Drug Res (Stuttg); 2016 Nov; 66(11):562-570. PubMed ID: 27504867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
    Liguori A; Morse WH; Bergman J
    J Pharmacol Exp Ther; 1996 Apr; 277(1):462-72. PubMed ID: 8613955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.